Form C — AlphaRose Therapeutics Inc
0001665160-25-000154 · filed Jan 29, 2025
· via StartEngine Primary, LLC
Offering
- Target
- $123,998
- Maximum
- $1,234,997
- Security type
- Common Stock
- Price per security
- $1.3500
- Deadline
- —
- Oversubscription
- Accepted
Issuer
- CIK
- 2051498
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 1401 LAVACA STREET, #851
AUSTIN, TX 78701 - Phone
- —
Most recent fiscal year financials
- Total assets
- $682,327
- Cash
- —
- Short-term debt
- $38,756
- Long-term debt
- $1,050,000
- Revenues
- —
- COGS
- —
- Taxes paid
- —
- Net income
- $-406,429
View the original filing on SEC EDGAR ↗